PTEN c.52_54delinsTGT ;(p.E18C)

Variant ID: 10-89624278-GAG-TGT

NM_000314.4(PTEN):c.52_54delinsTGT;(p.E18C)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Challenges for assessing replicability in preclinical cancer biology.

Elife
Errington, Timothy M TM; Denis, Alexandria A; Perfito, Nicole N; Iorns, Elizabeth E; Nosek, Brian A BA
Publication Date: 2021-12-07

Variant appearance in text: PTEN: E18C
PubMed Link: 34874008
Variant Present in the following documents:
  • Main text
View BVdb publication page



Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Tanioka, Maki M; Fan, Cheng C; Parker, Joel S JS; Hoadley, Katherine A KA; Hu, Zhiyuan Z; Li, Yan Y; Hyslop, Terry M TM; Pitcher, Brandelyn N BN; Soloway, Matthew G MG; Spears, Patricia A PA; Henry, Lynn N LN; Tolaney, Sara S; Dang, Chau T CT; Krop, Ian E IE; Harris, Lyndsay N LN; Berry, Donald A DA; Mardis, Elaine R ER; Winer, Eric P EP; Hudis, Clifford A CA; Carey, Lisa A LA; Perou, Charles M CM
Publication Date: 2018-11-01

Variant appearance in text: PTEN: E18C
PubMed Link: 30037817
Variant Present in the following documents:
  • Main text
View BVdb publication page